Telix Pharmaceuticals Limited (Asx: Tlx, Telix, The Company), A Global Biopharmaceutical Company Focused On The Development Of Diagnostic And Therapeutic Products Based On Molecularly Targeted Radiation (Mtr), Today Announces That The United States Food And Drug Administration (Fda) Has Approved Telix
